ETF Components for AGNG - Global X Aging Population ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
WELL A 0.32 3.10
AZN A 5.38 3.09
AMGN D -1.33 3.08
JNJ F -1.15 3.07
ABBV C -0.30 3.07
BMY F -8.51 3.06
BSX A 0.48 3.03
REGN D -1.75 3.00
MDT D -1.41 3.00
LLY D -1.00 2.94
EW C -0.68 2.91
SYK C 0.09 2.90
DXCM A 0.10 2.88
ZBH D -1.17 2.29
VTR C -0.57 1.60
NBIX B -0.87 1.23
BGNE D 3.08 1.16
INCY F -1.08 1.08
DVA B 0.02 1.07
PODD F -1.84 1.06
EXAS F -7.04 1.05
UTHR A -0.44 1.02
TFX F -2.11 0.90
OHI C 0.72 0.69
EXEL A -0.76 0.64
ENSG C -1.14 0.61
BPMC B -1.66 0.51
GKOS A -0.81 0.45
HALO D -1.69 0.45
MMSI C -0.88 0.39
ITGR B -9.83 0.36
NHI A -0.38 0.32
TBPH B -0.33 0.32
NHC C -0.40 0.31
EMBC F -4.50 0.30
AGIO A 0.00 0.30
AMED D 0.12 0.30
SBRA C -0.36 0.30
BKD A 1.63 0.30
MOR A 0.44 0.30
LIVN B -1.50 0.30
DCPH D -3.01 0.29
MNKD C -0.24 0.29
LTC A -0.16 0.29
ACAD F -1.69 0.29
AGL F -3.75 0.29
SILK B 0.46 0.28
ATEC F -3.92 0.28
ALEC F -8.38 0.25
DNLI F -3.86 0.25
NVCR F -0.89 0.25

Recent News for Global X Aging Population ETF & its Holdings

Date Stock Title
Apr 26 BMY Q1 2024 Bristol-Myers Squibb Co Earnings Call
Apr 26 BMY Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat
Apr 25 DXCM DexCom, Inc. (DXCM) Q1 2024 Earnings Call Transcript
Apr 25 DXCM Dexcom down 7% after hours despite quarterly beats, 2024 outlook updates
Apr 25 DXCM Dexcom's profit beats estimates on strong glucose monitor demand
Apr 25 NBIX Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data
Apr 25 DXCM DexCom (DXCM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Apr 25 EW Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics
Apr 25 EW Edwards Lifesciences Q1 Earnings: Mixed Results with Adjusted EPS Beating Estimates
Apr 25 DVA DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know
Apr 25 DXCM DexCom Inc (DXCM) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
Apr 25 EW Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates
Apr 25 EW Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff
Apr 25 ABBV Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Apr 25 DXCM Dexcom Plummets After Raising Its Sales Guidance For The Year — But Not Enough
Apr 25 HALO Mahesh Krishnan Elected to Halozyme's Board of Directors
Apr 25 DXCM DexCom, Inc. 2024 Q1 - Results - Earnings Call Presentation
Apr 25 BMY Bristol Myers Squibb stock tumbles on cost-cutting initiative
Apr 25 EW Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.02, revenue of $1.6B beats by $30M
Apr 25 EW Edwards Lifesciences Reports First Quarter Results
The investment seeks results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index. The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Biotechnology Structured Finance Pharmaceutical Financial Market Health Care Services
Back to the Main AGNG Page...